Reimagining America’s Future NFX General Partner Omri Drory discusses why longevity science is the most important national strategy no one’s talking about.

Reimagining America’s Future
NFX General Partner Omri Drory discusses why longevity science is the most important national strategy no one’s talking about.
#longevity #longevityinvestment #longevityeconomy

Why is human longevity a billionaire blind spot? NFX General Partner Omri Drory wonders why more billionaires aren’t backing the biggest health breakthrough of our time.

Why is human longevity a billionaire blind spot?
NFX General Partner Omri Drory wonders why more billionaires aren’t backing the biggest health breakthrough of our time.
#longevity #longevityinvestment #longevityeconomy

Juvenescence acquires Ro5 to bolster AI drug discovery Acquisition expected to support strategic collaboration with M42 on AI-enabled drug development hub in Abu Dhabi.

Juvenescence acquires Ro5 to bolster AI drug discovery
Acquisition expected to support strategic collaboration with M42 on AI-enabled drug development hub in Abu Dhabi.
#longevity #longevityinvestment #biotech #AI

Longevity Investor Network doubles in size in 2024 - Longevity.Technology - Latest News, Opinions, Analysis and Research Network’s investment strategy focuses on companies developing novel therapies for age-related conditions and biological rejuvenation.

Longevity Investor Network doubles in size in 2024
Network’s investment strategy focuses on companies developing novel therapies for age-related conditions and biological rejuvenation.
#longevity #longevityinvestment

Longevity 1.0 and the rise of the healthspan economy Phil Newman joins GWI’s podcast to discuss how the wellness industry is evolving to embrace longevity thinking and commercial opportunity.

Longevity 1.0 and the rise of the healthspan economy
Phil Newman joins GWI’s podcast to discuss how the wellness industry is evolving to embrace longevity thinking and commercial opportunity.
#longevity #longevityinvestment #longevityeconomy

AI and senolytics: Targeting brain aging at the cellular level University of Copenhagen receives Longevity Science Foundation grant to develop selective senolytics for neurodegeneration.

AI and senolytics: Targeting brain aging at the cellular level
University of Copenhagen receives Longevity Science Foundation grant to develop selective senolytics for neurodegeneration.
#longevity #longevityinvestment #longevityinnovation

USC launches longevity accelerator with $10m private donation Southern California initiative to focus on early intervention, aging subtype research and translation of preventative longevity therapies.

USC launches longevity accelerator with $10m private donation
Southern California initiative to focus on early intervention, aging subtype research and translation of preventative longevity therapies.
#longevity #longevityinvestment

Longevity Investors Conference returns to Gstaad in September Exclusive investor event brings together scientific and financial minds for curated dialogue on advancing human healthspan.

Longevity Investors Conference returns to Gstaad in September
Exclusive investor event brings together scientific and financial minds for curated dialogue on advancing human healthspan.
#longevity #longevityinvestment #longevityeconomy #event #conference #gstaad

Healthspan is the goal – function is the measure As the clinical phase begins, Peter Diamandis outlines the vision behind XPRIZE Healthspan and its challenge to rethink aging.

Healthspan is the goal – function is the measure
As the clinical phase begins, Peter Diamandis outlines the vision behind XPRIZE Healthspan and its challenge to rethink aging.
#longevity #longevityinvestment #longevityeconomy

Longevity investment more than doubles as sector shifts focus New report reveals $8.5b invested in 2024, with capital flowing to platform technologies and later-stage clinical development.

Longevity investment more than doubles as sector shifts focus
New report reveals $8.5b invested in 2024, with capital flowing to platform technologies and later-stage clinical development.
#longevity #longevityinvestment #longevityeconomy

M42 and Juvenescence collaborate on AI-enabled longevity drugs Abu Dhabi biotech collaboration aims to fast-track clinical-stage therapies that target the root mechanisms of aging and age-related disease.

M42 and Juvenescence collaborate on AI-enabled longevity drugs

Abu Dhabi biotech collaboration aims to fast-track clinical-stage therapies that target the root mechanisms of aging and age-related disease.

#longevity #longevitybiotech #longevityinvestment

Founders Longevity Forum reveals 2025 London agenda Agenda explores diagnostics, age reversal and preventative therapeutics as global leaders in science, tech and investment gather this June.

Founders Longevity Forum reveals 2025 London agenda
Agenda explores diagnostics, age reversal and preventative therapeutics as global leaders in science, tech and investment this June.
#longevity #longevityinvestment #longevityeconomy

Progress perspectives: Survey finds uncertainty on longevity gains Professionals across insurance, pensions and research share cautious optimism about life expectancy improvements in Club Vita's survey.

Progress perspectives: Survey finds uncertainty on longevity gains
Professionals across insurance, pensions and research share cautious optimism about life expectancy improvements in Club Vita’s survey.
#longevity #longevityinvestment #longevityeconomy